tobramycin has been researched along with Bacterial Eye Infections in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.98) | 18.7374 |
1990's | 24 (23.76) | 18.2507 |
2000's | 33 (32.67) | 29.6817 |
2010's | 40 (39.60) | 24.3611 |
2020's | 2 (1.98) | 2.80 |
Authors | Studies |
---|---|
Belov, DF; Deng, QQ; Jiang, H; Li, JL; Li, SH; Li, WJ; Luo, XQ; Nikolaenko, VP; She, TT; Wang, PD; Wang, Y; Yang, ZW | 1 |
Atta, S; Bhat, AK; Dhaliwal, D; Durrani, AF; Jhanji, V; Kowalski, RP; Mammen, A | 1 |
Borgman, CJ | 1 |
Culbertson, WW; Shah, P; Zhu, D | 1 |
Borderie, V; Georgeon, C; Ho-Wang-Yin, G; Knoeri, J | 1 |
Alfonso, EC; Gibbons, A; Miller, D; OʼBrien, TP; Palioura, S; Spierer, O | 1 |
Abdelkhalek, A; Bergstrom, BE; Hammac, GK; Seleem, MN; Townsend, WM; Younis, W | 1 |
Agarwal, P; Bansal, S; Goel, M; Sharma, N; Titiyal, JS; Upadhyaya, AD; Vajpayee, RB | 1 |
Blanco, AR; Papa, V; Spoto, CG; Sudano Roccaro, A | 1 |
Ohashi, Y; Suzuki, T | 1 |
Acuña, MF; Galvis, V; Guerra, AR; Tello, A; Villarreal, D | 1 |
Agarwal, P; Bansal, S; Goel, M; Sharma, N; Titiyal, J; Upadhyaya, A; Vajpayee, R | 1 |
Brynskov, T; Kemp, H; Sørensen, TL | 1 |
Boddu, SH; Bonam, SP; Jung, R | 1 |
Bianchi, PE; Bremond-Gignac, D; Chiambaretta, F; Delval, L; Hartani, D; Kaercher, T; Kocyla-Karczmarewicz, B; Lazreg, S; Messaoud, R; Murta, J; Nezzar, H; Renault, D; Speeg-Schatz, C; Voinea, L | 1 |
McDonald, EM; McGhee, CN; Patel, DV; Ram, FS | 1 |
Kwon, HJ; Lee, JS; Park, YM | 1 |
Eguchi, H; Hattori, T; Hoshi, S; Inoue, H; Inoue, T; Miyamoto, H; Nejima, R; Ohashi, Y; Suzuki, T; Todokoro, D | 1 |
Baviera, J; Beltran, J; Djodeyre, MR; Llovet-Osuna, F; Llovet-Rausell, A; Ortega-Usobiaga, J | 1 |
Al-Mohtaseb, Z; Amescua, G; Aziz, H; Garcia, N; Pantanelli, SM; Patel, R; Sise, A | 1 |
Abazari, A; Barash, A; Chou, TY; Kaplowitz, K; Shah, S | 1 |
Aptel, F; Boisset, S; Bron, AM; Chiquet, C; Creuzot-Garcher, C; Pechinot, A | 1 |
Agarwal, T; Arora, T; Jain, R; Jain, V; Satpathy, G; Sharma, N; Titiyal, J; Yadav, CP | 1 |
Fulcher, LC; Johnson, D; Jorgensen, J; Kiel, JW; McElmeel, ML; Montes, JA | 1 |
Kumar, JB; Silverstein, E; Wallace, DK | 1 |
Joo, CK; Lim, SA; Na, KS | 1 |
Bashir, H; Dave, A; Mathur, U | 1 |
Eisen, L; Kim, J; Rosenberg, J | 1 |
Cursiefen, C; Pollhammer, M | 1 |
Brown, SM; Fanning, WL; Raflo, GT | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Agarwal, T; Chawla, B; Nayak, N; Satpathy, G; Shah, VM; Sharma, N; Tandon, R; Titiyal, JS; Vajpayee, RB | 1 |
Brooks, CW; Demartelaere, SL; Johnson, AJ | 1 |
Chatziralli, IP; Papazisis, L; Sergentanis, TN | 1 |
Balzli, CL; Caballero, AR; McCormick, CC; O'Callaghan, RJ; Tang, A | 1 |
Kim, YH; Panday, V; Reilly, C | 1 |
Murphy, C; Pandita, A | 1 |
Lee, GA; Liang, SY | 1 |
Brown, GC; Garg, SJ; Haller, JA; Kaiser, RS; Shah, CP; Vander, JF | 1 |
Ding, Y; Li, Y; Lin, M; Liu, H; Wang, L; Zhang, W | 1 |
Gritz, DC; Rosenberg, JB | 1 |
Gabriel, M; Holden, BA; Ozkan, J; Willcox, MD; Zhu, H | 1 |
Goyal, S; Warner, DB | 1 |
Chen, ZJ; Han, L; Sun, ST; Wang, LY; Yue, J; Zhang, YQ | 1 |
Karenchak, LM; Kowalski, RP; Kowalski, TA; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Freilich, BD; Ramonas, KM | 1 |
Cheng, LL; Cheung, EY; Lam, DS; Leung, AT; Wong, AK; Young, AL | 1 |
Donnenfeld, ED; O'Brien, TP; Perry, HD; Solomon, R; Speaker, MG; Wittpenn, J | 1 |
Daines, BS; Sandoval, HP; Solomon, KD; Steed, LL; Vroman, DT | 1 |
Sloan, B; Watson, A | 1 |
Fleiszig, SM; Lee, EJ; Mendoza, MN; Truong, TN | 1 |
Akduman, L; Lee, DH; Oz, O; Smetana, SM | 1 |
Alió, JL; Ferrer, C; Montero, J; Rodríguez, A; Ruiz-Moreno, JM | 1 |
Adrean, SD; Cochrane, R; Mannis, MJ; Reilly, CD | 1 |
Carstocea, B; Di Bella, A; Favero, A; Gafencu, O; Milazzo, G; Papa, V; Radulescu, C; Russo, S | 1 |
Lee, SB; Mohan, SK; Oliver, KM; Slomovic, AR; Strube, YN | 1 |
Eiferman, RA; Hamrah, P; Ritterband, D; Seedor, J | 1 |
Sharma, N; Singhvi, A; Sinha, R; Tandon, R | 1 |
Akova, YA; Gedik, S; Gür, S | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA | 1 |
Bouchard, CS; Bu, P; Carey, R; Riske, PS; Zaya, NE | 1 |
Jhanji, V; Satpathy, G; Sharma, N; Titiyal, J | 1 |
Chen, CH; Chen, CL; Chen, JT; Lu, DW; Tai, MC | 1 |
Constantinou, M; Daniell, M; Snibson, GR; Taylor, HR; Vu, HT | 1 |
Downer, DM; Gohari, AR; Park, HJ; Shah, M; Tuli, SS | 1 |
Faia, LJ; Griepentrog, GJ; Schornack, MM | 1 |
Balzli, C; Caballero, A; McCormick, C; O'Callaghan, R; Song, J; Tang, A | 1 |
Alfonso, E; Fink, NE; Maguire, MG; McDonnell, P; O'Brien, TP | 1 |
Callegan, MC; Clinch, TE; Engel, LS; Hill, JM; Kaufman, HE; O'Callaghan, RJ | 1 |
Callegan, MC; Engel, LS; Hill, JM; Hobden, JA; O'Callaghan, RJ; Reidy, JJ | 1 |
Carta, A; Carta, F; Fadda, G; Pinna, A; Sotgiu, M; Zanetti, S | 1 |
Callegan, MC; Engel, LS; Hill, JM; O'Callaghan, RJ | 1 |
Amdahl, LD; Cheetham, JK; Osher, RH | 1 |
Cohen, KL; Lauffenburger, MD | 1 |
Maskin, SL | 1 |
Baker, RS; Casey, R; Flowers, CW; Fong, DS; Wilson, MR | 1 |
Adenis, JP; Badrinath, SS; Caldwell, DR; Eiferman, RA; Hyndiuk, RA; Katz, HR; Klauss, V; Reddy, MK; Rosenwasser, GO; Santos, CI | 1 |
Cohen, EJ; Laibson, PR; Lois, N; Rapuano, CJ | 1 |
Donzis, PB | 1 |
Chaudhry, NA; Davis, J; Miller, D; Rosenfeld, PJ; Tabandeh, H | 1 |
Ahuja, R; Panda, A; Sastry, SS | 1 |
Dada, T; Dada, VK; Sharma, N; Vajpayee, RB | 1 |
Daniell, M; Gangopadhyay, N; Taylor, HR; Weih, L | 1 |
Alexandrakis, G; Alfonso, EC; Miller, D | 1 |
Adenis, JP; Robert, PY | 1 |
Cohen, EJ; Laibson, PR; Rapuano, CJ; Sridhar, MS | 1 |
Campbell, I; Herzig, S; Rootman, DS; Suresh, PS | 1 |
Cappuccinelli, P; Carta, F; Delogu, G; Pinna, A; Sechi, LA; Usai, D; Zanetti, S | 1 |
Caballero, AR; Dajcs, JJ; Girgis, DO; Ke, TL; Moreau, JM; O'Callaghan, RJ; Schlech, BA; Stroman, DW; Thibodeaux, BA | 1 |
Clinch, TE; Engel, LS; Hill, JM; Hobden, JA; Kaufmann, HE; O'Callaghan, RJ | 1 |
Assil, KK; Brown, SI; Douglas, H; Frucht-Perry, J; Schanzlin, DJ; Weinreb, RN; Ziegler, E | 1 |
Gonzalez, VH; Gritz, DC; Kwitko, S; McDonnell, PJ; Trousdale, MD | 1 |
Gandolfi, SA; Massari, A; Orsoni, JG | 1 |
Assil, KK; Fouraker, BD; Schanzlin, DJ; Zarnegar, SR | 1 |
Gritz, DC; Gwon, A; Hubbard, BB; Lee, TY; McDonnell, PJ; Tang-Liu, D | 1 |
Assil, KK; Frucht-Perry, J; Schanzlin, DJ; Schneiderman, T; Weinreb, RN; Ziegler, E | 1 |
Arentsen, JJ; Cohen, EJ; Laibson, PR; Marioneaux, SJ | 1 |
Aiken, TB; Diskin, JA; Dunn, SP; Heidemann, DG | 1 |
Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ; Reidy, JJ | 1 |
Hill, JM; Hobden, JA; O'Callaghan, RJ; Reidy, JJ; Rootman, DS; Thompson, HW | 1 |
Gilbert, ML; Osato, MS; Wilhelmus, KR | 1 |
4 review(s) available for tobramycin and Bacterial Eye Infections
Article | Year |
---|---|
Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
Topics: Administration, Topical; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Fluoroquinolones; Humans; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Infectious keratitis after photorefractive keratectomy.
Topics: Adult; Ciprofloxacin; Corneal Ulcer; Cross Infection; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Lasers, Excimer; Methicillin Resistance; Photorefractive Keratectomy; Polymyxins; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Tobramycin; Trimethoprim; Visual Acuity | 2003 |
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Indicators and Reagents; Keratomileusis, Laser In Situ; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Postoperative Complications; Staining and Labeling; Tobramycin | 2003 |
Comparative review of topical ophthalmic antibacterial preparations.
Topics: Administration, Topical; Anti-Bacterial Agents; Chloramphenicol; Eye Infections, Bacterial; Fusidic Acid; Gentamicins; Humans; Quinolones; Tobramycin; Trachoma | 2001 |
13 trial(s) available for tobramycin and Bacterial Eye Infections
Article | Year |
---|---|
Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prevalence; Prospective Studies; Quinolines; Therapeutic Equivalency; Tobramycin; Treatment Outcome; Visual Acuity | 2013 |
Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Azithromycin; Bacteria; Child; Child, Preschool; Conjunctivitis, Bacterial; Eye Infections, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Ophthalmic Solutions; Tobramycin; Treatment Outcome | 2014 |
Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Cornea; Corneal Ulcer; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Tobramycin; Treatment Outcome; Visual Acuity | 2016 |
Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome; Visual Acuity; Young Adult | 2010 |
Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Corneal Edema; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Follow-Up Studies; Glucocorticoids; Humans; Keratitis; Ketorolac; Male; Phacoemulsification; Postoperative Care; Postoperative Complications; Risk Factors; Tobramycin; Treatment Outcome; Visual Acuity | 2011 |
Effect of prophylactic antibiotic drops on ocular microbiota and physiology during silicone hydrogel lens wear.
Topics: Adult; Anti-Bacterial Agents; Contact Lenses, Extended-Wear; Cornea; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Keratitis; Male; Metagenome; Ophthalmic Solutions; Prospective Studies; Silicones; Time Factors; Tobramycin; Treatment Outcome | 2012 |
Dexamethasone-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Dexamethasone; Double-Blind Method; Drug Combinations; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Male; Middle Aged; Netilmicin; Phacoemulsification; Postoperative Care; Prospective Studies; Surgical Wound Infection; Tobramycin; Treatment Outcome; Visual Acuity | 2007 |
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Child; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome | 2007 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Cornea; Corneal Ulcer; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Tobramycin; Treatment Outcome | 1995 |
Antimicrobial efficacy and aqueous humor concentration of preoperative and postoperative topical trimethoprim/polymyxin B sulfate versus tobramycin.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Cataract Extraction; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Lenses, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Polymyxin B; Premedication; Tobramycin; Trimethoprim | 1994 |
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefazolin; Cephalosporins; Child; Ciprofloxacin; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tobramycin | 1996 |
Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Staphylococcal Infections; Tobramycin; Visual Acuity | 1999 |
Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers.
Topics: Adolescent; Adult; Aged; Corneal Ulcer; Double-Blind Method; Drug Carriers; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Male; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Tobramycin; Treatment Outcome | 1992 |
84 other study(ies) available for tobramycin and Bacterial Eye Infections
Article | Year |
---|---|
Topics: Anti-Bacterial Agents; Bacillaceae; Cataract; Cataract Extraction; China; Dexamethasone; Endophthalmitis; Estuaries; Eye Infections, Bacterial; Genome, Bacterial; Geologic Sediments; Humans; Levofloxacin; Phylogeny; Postoperative Complications; Povidone-Iodine; Retrospective Studies; Tobramycin | 2023 |
Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Corneal Ulcer; Drug Combinations; Eye Infections, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Staphylococcal Infections; Tobramycin; Treatment Outcome; Vancomycin | 2020 |
Recurrent conjunctivitis secondary to Gram-positive bacillus, Bacillus thuringiensis.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Bacillus thuringiensis; Conjunctivitis, Bacterial; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Recurrence; Tobramycin | 2018 |
Therapeutic Femtosecond Laser-Assisted Lamellar Keratectomy for Multidrug-Resistant Nocardia Keratitis.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Corneal Surgery, Laser; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Humans; Male; Nocardia asteroides; Nocardia Infections; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
[Nocardia keratitis: Case report].
Topics: Anti-Bacterial Agents; Benzamidines; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluorescein Angiography; Humans; Hydroxymercuribenzoates; Keratitis; Nocardia Infections; Tobramycin; Young Adult | 2018 |
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Antibacterial activity and safety of commercial veterinary cationic steroid antibiotics and neutral superoxidized water.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cations; Cell Line; Dog Diseases; Dogs; Drug Resistance, Microbial; Eye; Eye Infections, Bacterial; Gentamicins; Humans; Hydrogen Peroxide; Mice; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Steroids; Tobramycin; Veterinary Drugs | 2018 |
Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Chloramphenicol; Drug Resistance; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Netilmicin; Quinolines; Staphylococcus epidermidis; Tobramycin; Vancomycin | 2013 |
Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefmenoxime; Corneal Ulcer; Drug Combinations; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Streptococcus; Tobramycin | 2013 |
Fluoroquinolones in corneal ulcers.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Corneal Ulcer; Eye Infections, Bacterial; Female; Humans; Male; Quinolines; Tobramycin | 2013 |
Author reply: To PMID 23415776.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Corneal Ulcer; Eye Infections, Bacterial; Female; Humans; Male; Quinolines; Tobramycin | 2013 |
No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting.
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Infective Agents, Local; Denmark; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Operating Rooms; Povidone-Iodine; Practice Patterns, Physicians'; Respiratory Protective Devices; Retinal Diseases; Tobramycin; Vascular Endothelial Growth Factor A | 2014 |
Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
Topics: Abattoirs; Administration, Cutaneous; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cattle; Dexamethasone; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Liberation; Excipients; Eye Infections, Bacterial; Eyelids; Gels; Humans; Lecithins; Poloxamer; Pseudomonas aeruginosa; Ricinoleic Acids; Skin Absorption; Tobramycin; Viscosity | 2015 |
Microbiological study of therapeutic soft contact lenses used in the treatment of recurrent corneal erosion syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Child; Citrobacter freundii; Contact Lenses, Hydrophilic; Corneal Diseases; Enterobacter; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Staphylococcus epidermidis; Tobramycin; Young Adult | 2015 |
Clinical Characteristics and Bacteriological Profile of Moraxella Keratitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefmenoxime; Child; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Injuries; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella; Moraxellaceae Infections; Retrospective Studies; Risk Factors; Tobramycin | 2015 |
Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Incidence; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Moxifloxacin; Myopia; Ophthalmic Solutions; Postoperative Complications; Retrospective Studies; Risk Factors; Tobramycin; Visual Acuity; Young Adult | 2015 |
Nocardia asteroides Keratitis Resistant to Amikacin.
Topics: Administration, Topical; Amikacin; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Bacterial; Female; Humans; Kanamycin Resistance; Microbial Sensitivity Tests; Nocardia asteroides; Nocardia Infections; Ophthalmic Solutions; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2015 |
Early-onset methicillin-resistant Staphylococcus aureus keratitis and late-onset infectious keratitis in astigmatic keratotomy incision following femtosecond laser-assisted cataract surgery.
Topics: Aged; Anti-Bacterial Agents; Astigmatism; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratotomy, Radial; Laser Therapy; Methicillin-Resistant Staphylococcus aureus; Phacoemulsification; Staphylococcal Infections; Surgical Wound Infection; Tobramycin; Tomography, Optical Coherence; Vancomycin; Visual Acuity | 2015 |
Massilia timonae as cause of chronic endophthalmitis following cataract surgery.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Chronic Disease; DNA, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Microbial Sensitivity Tests; Oxalobacteraceae; Phacoemulsification; Polymerase Chain Reaction; Postoperative Complications; RNA, Ribosomal, 16S; Tobramycin; Vancomycin | 2015 |
Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
Topics: Anti-Bacterial Agents; Drug Stability; Drug Storage; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Infertility; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Prospective Studies; Temperature; Time Factors; Tobramycin; Vancomycin | 2016 |
Klebsiella pneumonia: An unusual cause of ophthalmia neonatorum in a healthy newborn.
Topics: Anti-Bacterial Agents; Eye Infections, Bacterial; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Ophthalmia Neonatorum; Ophthalmic Solutions; Tobramycin | 2015 |
Clinical Features of Infectious Keratitis Caused by Propionibacterium Acnes.
Topics: Adult; Aged; Anti-Bacterial Agents; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Propionibacterium acnes; Tobramycin; Young Adult | 2017 |
Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
Topics: Anti-Bacterial Agents; Cefazolin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Tobramycin | 2016 |
Moxifloxacin for bacterial keratitis.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome | 2008 |
Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Collagen; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Eye Infections, Bacterial; Humans; Keratoconus; Male; Photochemotherapy; Photosensitizing Agents; Postoperative Complications; Riboflavin; Tobramycin; Ultraviolet Rays; Visual Acuity | 2009 |
Transconjunctival orbital invasion by methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Conjunctivitis; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Orbital Diseases; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2009 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Spontaneous subconjunctival abscess because of Haemophilus influenzae.
Topics: Abscess; Adult; Anti-Infective Agents; Aza Compounds; Conjunctival Diseases; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Moxifloxacin; Quinolines; Tobramycin; Tomography, X-Ray Computed; Vancomycin | 2010 |
The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Cornea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Polysaccharides, Bacterial; Prednisolone; Pseudomonas Infections; Rabbits; Tobramycin | 2010 |
Isolation of Kingella denitrificans from a corneal ulcer.
Topics: Aged; Anti-Bacterial Agents; Corneal Ulcer; Eye Infections, Bacterial; Humans; Keratitis, Herpetic; Keratoplasty, Penetrating; Kingella; Male; Neisseriaceae Infections; Reoperation; Tobramycin | 2011 |
Microbial keratitis in Waikato, New Zealand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Child; Child, Preschool; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; New Zealand; Retrospective Studies; Tobramycin | 2011 |
Intrastromal injection of antibiotic agent in the management of recalcitrant bacterial keratitis.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Corneal Stroma; Corneal Ulcer; Eye Infections, Bacterial; Humans; Injections, Intraocular; Lens Implantation, Intraocular; Male; Phacoemulsification; Recurrence; Staphylococcal Infections; Surgical Wound Infection; Tobramycin | 2011 |
Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Case-Control Studies; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Ranibizumab; Retrospective Studies; Risk Factors; Tobramycin; Treatment Outcome; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2011 |
Outcomes of post-cataract surgery endophthalmitis referred to a tertiary center from local hospitals in the south of China.
Topics: Aged, 80 and over; Anti-Infective Agents; Aspergillus fumigatus; Cataract Extraction; China; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, Rural; Humans; Incidence; Intravitreal Injections; Lens, Crystalline; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Time Factors; Tobramycin; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Body | 2011 |
Monotherapy versus fortified antibiotics for bacterial keratitis.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Quinolines; Tobramycin | 2011 |
Roseomonas keratitis after remote penetrating keratoplasty.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Corneal Perforation; Corneal Ulcer; Eye Infections, Bacterial; Female; Fuchs' Endothelial Dystrophy; Gram-Negative Bacterial Infections; Humans; Keratoplasty, Penetrating; Methylobacteriaceae; Surgical Wound Infection; Tobramycin; Visual Acuity | 2013 |
[The changes of ocular bacterial isolates and in vitro antimicrobial susceptibility in the past six years].
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus epidermidis; Tobramycin | 2012 |
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cefuroxime; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tobramycin | 2013 |
Iris abscess as an unusual presentation of endogenous endophthalmitis in a patient with bacterial endocarditis.
Topics: Abscess; Adult; Anterior Chamber; Bacteremia; Ceftazidime; Dexamethasone; Drug Therapy, Combination; Endocarditis, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Humans; Iris Diseases; Male; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2003 |
Orthokeratology lens-related Pseudomonas aeruginosa infectious keratitis.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Myopia; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Visual Acuity | 2003 |
Ecthyma gangrenosum arising from Pseudomonas aeruginosa dacryocystitis.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Dacryocystitis; Dacryocystorhinostomy; Debridement; Drug Therapy, Combination; Ecthyma; Eye Infections, Bacterial; Eyelid Diseases; Female; Gangrene; Humans; Intubation; Pseudomonas Infections; Skin; Tobramycin; Tomography, X-Ray Computed | 2003 |
A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Mice; Mice, Inbred C57BL; Ofloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
A case of infected scleral buckle with Mycobacterium chelonae associated with chronic intraocular inflammation.
Topics: Anti-Bacterial Agents; Chronic Disease; Device Removal; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Humans; Iridocyclitis; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prosthesis-Related Infections; Reoperation; Scleral Buckling; Scleritis; Tobramycin | 2004 |
Postoperative Corynebacterium macginleyi endophthalmitis.
Topics: Aged; Aqueous Humor; Bacterial Typing Techniques; Cataract Extraction; Chronic Disease; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gene Amplification; Humans; Lens Implantation, Intraocular; Male; Ofloxacin; Polymerase Chain Reaction; Postoperative Complications; Tobramycin; Vancomycin; Vitreous Body | 2004 |
Infectious keratitis after astigmatic keratotomy in penetrating keratoplasty: review of three cases.
Topics: Astigmatism; Cefazolin; Cornea; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fuchs' Endothelial Dystrophy; Humans; Keratitis; Keratitis, Herpetic; Keratoplasty, Penetrating; Keratotomy, Radial; Male; Middle Aged; Postoperative Complications; Pseudomonas Infections; Staphylococcal Infections; Tobramycin | 2005 |
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Surgical Flaps; Tobramycin | 2005 |
Ocular infection secondary to gemella.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Staphylococcaceae; Tobramycin; Vancomycin | 2006 |
Pseudomonas keratitis after laser in situ keratomileusis.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cephalosporin Resistance; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Kanamycin Resistance; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Postoperative Complications; Pseudomonas Infections; Tobramycin | 2006 |
Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis.
Topics: Anti-Bacterial Agents; Cefazolin; Child; Conjunctivitis, Allergic; Corneal Ulcer; Cyclopentolate; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Oxamic Acid; Prednisolone; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2006 |
Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens; Tobramycin | 2007 |
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Chlorhexidine; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Combinations; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2007 |
Fourth-generation fluoroquinolone-resistant bacterial keratitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 2007 |
Infectious crystalline keratopathy caused by Serratia marcescens.
Topics: Aged; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cornea; Corneal Diseases; Debridement; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluorometholone; Glucocorticoids; Humans; Keratoplasty, Penetrating; Serratia Infections; Serratia marcescens; Tobramycin | 2007 |
Shewanella putrefaciens keratitis in the lamellar bed 6 years after LASIK.
Topics: Anti-Bacterial Agents; Cefazolin; Corneal Stroma; Drug Therapy, Combination; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Middle Aged; Postoperative Complications; Reoperation; Shewanella putrefaciens; Surgical Flaps; Tobramycin | 2007 |
Pseudomonas keratitis associated with daily wear of silicone hydrogel contact lenses.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Contact Lenses, Hydrophilic; Corneal Ulcer; Cyclopentolate; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Silicone Elastomers; Tobramycin | 2008 |
Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
Topics: Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Compounding; Eye Infections, Bacterial; Keratitis; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Tobramycin; Treatment Outcome | 2008 |
Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
Topics: Administration, Topical; Animals; Collagen; Colony Count, Microbial; Cornea; Drug Delivery Systems; Eye Infections, Bacterial; Keratitis; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1994 |
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Keratitis; Ophthalmic Solutions; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1995 |
Corneal ulcer caused by Aeromonas species.
Topics: Aeromonas hydrophila; Contact Lenses; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Eye Injuries; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Tobramycin | 1994 |
Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Drug Administration Schedule; Eye Infections, Bacterial; Keratitis; Methicillin Resistance; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1994 |
Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1993 |
Infectious scleritis after a diabetic foot ulcer.
Topics: Administration, Oral; Administration, Topical; Ciprofloxacin; Diabetes Mellitus; Drug Therapy, Combination; Erythromycin; Eye Infections, Bacterial; Foot Ulcer; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Scleritis; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1993 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Clinical Trials as Topic; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Tobramycin | 1996 |
Contact lens use after contact lens-associated infectious ulcers.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Middle Aged; Ophthalmic Solutions; Refractive Errors; Retrospective Studies; Tobramycin; Visual Acuity | 1997 |
Corneal ulcer associated with contamination of aerosol saline spray tip.
Topics: Aerosols; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Bacterial; Female; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Chloride; Tobramycin | 1997 |
Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Retinal Detachment; Scleral Buckling; Tobramycin | 1998 |
Pneumococcal keratitis after laser in situ keratomileusis.
Topics: Adult; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratomileusis, Laser In Situ; Male; Myopia; Ophthalmic Solutions; Pneumococcal Infections; Streptococcus pneumoniae; Surgical Wound Infection; Tobramycin; Visual Acuity | 2000 |
Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefazolin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Tobramycin; Treatment Outcome; Visual Acuity | 2000 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; Florida; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Tobramycin | 2000 |
Infectious crystalline keratopathy in an immunosuppressed patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cefazolin; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Immunosuppression Therapy; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus; Tobramycin; Visual Acuity | 2001 |
Mycobacterium keratitis following hyperopic laser in situ keratomileusis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cornea; Drug Resistance, Microbial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Hyperopia; Keratitis; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prednisolone; Tobramycin | 2001 |
Bacillus cereus keratitis associated with contact lens wear.
Topics: Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Conjunctiva; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Corneal Ulcer; Disinfection; DNA, Bacterial; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Bacterial; Hot Temperature; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Tobramycin | 2001 |
The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Colony Count, Microbial; Corneal Stroma; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2001 |
Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
Topics: Animals; Biological Dressings; Collagen; Colony Count, Microbial; Cornea; Corneal Ulcer; Delayed-Action Preparations; Disease Models, Animal; Eye Infections, Bacterial; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1992 |
Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Carriers; Eye Infections, Bacterial; Fibrin; Liposomes; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Tobramycin | 1992 |
Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Methylprednisolone; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Recurrence; Streptococcus pneumoniae; Tobramycin | 1992 |
Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits.
Topics: Administration, Topical; Animals; Biological Dressings; Collagen; Colony Count, Microbial; Cornea; Drug Carriers; Eye Infections, Bacterial; Eyelids; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1992 |
Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
Topics: Administration, Topical; Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Pseudomonas Infections; Rabbits; Tobramycin | 1992 |
Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
Topics: Administration, Topical; Animals; Colony Count, Microbial; Conjunctiva; Drug Carriers; Eye Infections, Bacterial; Keratitis; Liposomes; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Tobramycin | 1991 |
Moraxella keratitis.
Topics: Adult; Aged; Aged, 80 and over; Cefazolin; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Moraxella; Reoperation; Retrospective Studies; Tobramycin; Visual Acuity | 1991 |
Corynebacterium striatus keratitis.
Topics: Aged; Aged, 80 and over; Cefazolin; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Tobramycin | 1991 |
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Topics: Animals; Ciprofloxacin; Collagen; Colony Count, Microbial; Cornea; Drug Resistance, Microbial; Eye Infections, Bacterial; Keratitis; Norfloxacin; Pharmaceutical Vehicles; Pseudomonas aeruginosa; Quinolones; Rabbits; Tobramycin | 1990 |
Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
Topics: Administration, Topical; Animals; Conjugation, Genetic; Cornea; Drug Resistance, Microbial; Eye Infections, Bacterial; Iontophoresis; Keratitis; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors; Rabbits; Random Allocation; Tobramycin | 1989 |
Intracanalicular collagen implants enhance topical antibiotic bioavailability.
Topics: Administration, Topical; Animals; Biological Availability; Collagen; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Lacrimal Duct Obstruction; Prostheses and Implants; Pseudomonas Infections; Rabbits; Tears; Tobramycin | 1986 |